About The Study: In this cohort study, oseltamivir treatment during influenza episodes was associated with a reduced risk of serious neuropsychiatric events among children and adolescents. These findings support oseltamivir use for prevention of these influenza-related complications.
Corresponding Author: To contact the corresponding author, James W. Antoon, MD, PhD, MPH, email james.antoon@vumc.org .
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaneurol.2025.1995)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2025.1995?guestAccessKey=11df0d27-af92-4125-9b4f-79882c523cc7&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=080425
JAMA Neurology